These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34525243)

  • 1. The impact of myasthenia gravis on lower urinary tract functions.
    Akan O; Polat EC; Çulha MG; Önol SD
    Int J Clin Pract; 2021 Dec; 75(12):e14873. PubMed ID: 34525243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the International Consultation on Incontinence Questionnaires Bladder Diary in Men Seeking therapy for Lower Urinary Tract Symptoms.
    Ito H; Abrams P; Lewis AL; Young GJ; Blair PS; Cotterill N; Lane JA; Drake MJ
    Eur Urol Focus; 2022 Jan; 8(1):66-74. PubMed ID: 35027329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can botox improve night-time overactive bladder symptoms in women?
    Miotla P; Cartwright R; Futyma K; Bogusiewicz M; Skorupska K; Winkler I; Rechberger T
    Neurourol Urodyn; 2017 Mar; 36(3):648-652. PubMed ID: 26915654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein levels in girls with lower urinary tract symptoms.
    Tarhan H; Ekin RG; Can E; Cakmak O; Yavascan O; Mutlubas Ozsan F; Helvaci M; Zorlu F
    J Pediatr Urol; 2016 Apr; 12(2):105.e1-4. PubMed ID: 26497919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary.
    Bright E; Cotterill N; Drake M; Abrams P
    Eur Urol; 2014 Aug; 66(2):294-300. PubMed ID: 24647230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical differences of early and late-onset myasthenia gravis in 985 patients.
    Fan L; Ma S; Yang Y; Yan Z; Li J; Li Z
    Neurol Res; 2019 Jan; 41(1):45-51. PubMed ID: 30311866
    [No Abstract]   [Full Text] [Related]  

  • 7. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
    Xue Z; Lin Y; Jiang Y; Wei N; Bi J
    BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are voiding volumes and frequencies different in the three-day voiding diary in children with lower urinary tract dysfunction?
    Ergun R; Sekerci CA; Cetin M; Sahak MY; Yucel S; Tarcan T
    Arch Ital Urol Androl; 2023 Oct; 95(3):11662. PubMed ID: 37791547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing clinical bladder diaries and recalled patient reports for measuring lower urinary tract symptoms in the symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).
    Flynn KE; Wiseman JB; Helmuth ME; Smith AR; Bradley CS; Cameron AP; Henry Lai H; Kirkali Z; Kreder KJ; Geynisman-Tan J; Merion RM; Weinfurt KP;
    Neurourol Urodyn; 2022 Nov; 41(8):1711-1721. PubMed ID: 36066068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
    Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
    J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of transverse diameter of the rectum in lower urinary tract symptoms and functional constipation in children and adolescents.
    de Abreu GE; de Souza LA; Dourado ER; Schimitz AP; Veiga ML; Barroso U
    J Paediatr Child Health; 2021 Jan; 57(1):121-125. PubMed ID: 32932552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
    Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
    Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Nonresponders.
    Khusid JA; Weiss JP; Carlsson MO; Mangan EK
    J Urol; 2017 Nov; 198(5):1119-1123. PubMed ID: 28479240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.
    Jung HB; Choi DK; Lee SH; Cho ST; Na HR; Park MH
    Int Braz J Urol; 2017; 43(2):256-263. PubMed ID: 27802001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?
    Bang WJ; Lee JY; Koo KC; Hah YS; Lee DH; Cho KS
    Urology; 2014 Sep; 84(3):670-4. PubMed ID: 25168549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.
    Hsiao SM; Lin HH; Kuo HC
    Int Urogynecol J; 2013 Feb; 24(2):263-7. PubMed ID: 22588143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of cue-induced urinary urges to nocturia in women ages 18 to 40 years.
    Singer J; O'Connell KA
    Neurourol Urodyn; 2019 Jun; 38(5):1378-1383. PubMed ID: 30939224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms.
    Shin YS; Zhang LT; Zhao C; Kim YG; Park JK
    Clin Interv Aging; 2014; 9():1021-30. PubMed ID: 25031529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.